{"id":"https://openalex.org/W2004307680","doi":"https://doi.org/10.1016/j.acuro.2010.11.008","title":"Coste-efectividad de la combinaci\u00f3n dutasterida y tamsulosina en el tratamiento de la hiperplasia benigna de pr\u00f3stata en Espa\u00f1a","display_name":"Coste-efectividad de la combinaci\u00f3n dutasterida y tamsulosina en el tratamiento de la hiperplasia benigna de pr\u00f3stata en Espa\u00f1a","publication_year":2011,"publication_date":"2011-02-01","ids":{"openalex":"https://openalex.org/W2004307680","doi":"https://doi.org/10.1016/j.acuro.2010.11.008","mag":"2004307680","pmid":"https://pubmed.ncbi.nlm.nih.gov/21269736"},"language":"es","primary_location":{"id":"doi:10.1016/j.acuro.2010.11.008","doi":"https://doi.org/10.1016/j.acuro.2010.11.008","is_oa":false,"landing_page_url":"https://doi.org/10.1016/j.acuro.2010.11.008","pdf_url":null,"source":{"id":"https://openalex.org/S38879697","display_name":"Actas Urol\u00f3gicas Espa\u00f1olas","issn_l":"0210-4806","issn":["0210-4806","1699-7980"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","doyens","jufo-1","norway-1","poland-40","russia-white-list-3"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Actas Urol\u00f3gicas Espa\u00f1olas","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"hybrid","oa_url":"https://scielo.isciii.es/pdf/aue/v35n2/original1.pdf","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5011482910","display_name":"Fernando Anto\u00f1anzas","orcid":"https://orcid.org/0000-0001-6122-9130","observed_orcids":["https://orcid.org/0000-0001-6122-9130"]},"institutions":[{"id":"https://openalex.org/I168974976","display_name":"Universidad de La Rioja","ror":"https://ror.org/0553yr311","country_code":"ES","type":"education","lineage":["https://openalex.org/I168974976"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"F. Anto\u00f1anzas","raw_affiliation_strings":["Departamento de Econom\u00eda Aplicada, Universidad de la Rioja, Logro\u00f1o, Espa\u00f1a"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Departamento de Econom\u00eda Aplicada, Universidad de la Rioja, Logro\u00f1o, Espa\u00f1a","institution_ids":["https://openalex.org/I168974976"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5028522311","display_name":"Francisco Jos\u00e9 Brenes","orcid":"https://orcid.org/0000-0002-0932-6678","observed_orcids":["https://orcid.org/0000-0002-0932-6678"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"F. Brenes","raw_affiliation_strings":["Centro de Atenci\u00f3n Primaria Llefi\u00e0 (ABS6), Badalona, Barcelona, Espa\u00f1a"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Centro de Atenci\u00f3n Primaria Llefi\u00e0 (ABS6), Badalona, Barcelona, Espa\u00f1a","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5022910556","display_name":"Jos\u00e9 Molero","orcid":"https://orcid.org/0000-0002-4426-2593","observed_orcids":["https://orcid.org/0000-0002-4426-2593"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"J.M. Molero","raw_affiliation_strings":["Centro de Salud San Andr\u00e9s, Madrid, Espa\u00f1a"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Centro de Salud San Andr\u00e9s, Madrid, Espa\u00f1a","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5055967645","display_name":"Antonio Fern\u00e1ndez-Pro","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"A. Fern\u00e1ndez-Pro","raw_affiliation_strings":["Centro de Salud de Menasalbas, Toledo, Espa\u00f1a"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Centro de Salud de Menasalbas, Toledo, Espa\u00f1a","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5012588685","display_name":"Alicia Huerta","orcid":"https://orcid.org/0000-0003-0287-4142","observed_orcids":["https://orcid.org/0000-0003-0287-4142"]},"institutions":[{"id":"https://openalex.org/I4210151147","display_name":"GlaxoSmithKline (Spain)","ror":"https://ror.org/049nnjd96","country_code":"ES","type":"company","lineage":["https://openalex.org/I188950975","https://openalex.org/I4210151147"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"A. Huerta","raw_affiliation_strings":["GlaxoSmithKline, Tres Cantos, Madrid, Espa\u00f1a"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"GlaxoSmithKline, Tres Cantos, Madrid, Espa\u00f1a","institution_ids":["https://openalex.org/I4210151147"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5020083885","display_name":"R. Palencia","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210151147","display_name":"GlaxoSmithKline (Spain)","ror":"https://ror.org/049nnjd96","country_code":"ES","type":"company","lineage":["https://openalex.org/I188950975","https://openalex.org/I4210151147"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"R. Palencia","raw_affiliation_strings":["GlaxoSmithKline, Tres Cantos, Madrid, Espa\u00f1a"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"GlaxoSmithKline, Tres Cantos, Madrid, Espa\u00f1a","institution_ids":["https://openalex.org/I4210151147"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5110169654","display_name":"Jose M. Cozar","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210116170","display_name":"Hospital Universitario Virgen de las Nieves","ror":"https://ror.org/02f01mz90","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I4210116170"]}],"countries":["ES"],"is_corresponding":true,"raw_author_name":"J.M. Cozar","raw_affiliation_strings":["Servicio de Urolog\u00eda, Hospital Universitario Virgen de las Nieves, Granada, Espa\u00f1a"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Servicio de Urolog\u00eda, Hospital Universitario Virgen de las Nieves, Granada, Espa\u00f1a","institution_ids":["https://openalex.org/I4210116170"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":3,"corresponding_author_ids":["https://openalex.org/A5110169654"],"corresponding_institution_ids":["https://openalex.org/I4210116170"],"apc_list":{"value":2760,"currency":"USD","value_usd":2760},"apc_paid":{"value":2760,"currency":"USD","value_usd":2760},"fwci":1.749,"has_fulltext":false,"cited_by_count":20,"citation_normalized_percentile":{"value":0.84259373,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":98},"biblio":{"volume":"35","issue":"2","first_page":"65","last_page":"71"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10279","display_name":"Urinary Bladder and Prostate Research","score":0.6826000213623047,"subfield":{"id":"https://openalex.org/subfields/2748","display_name":"Urology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10279","display_name":"Urinary Bladder and Prostate Research","score":0.6826000213623047,"subfield":{"id":"https://openalex.org/subfields/2748","display_name":"Urology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10804","display_name":"Health Systems, Economic Evaluations, Quality of Life","score":0.2904999852180481,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T10124","display_name":"Prostate Cancer Diagnosis and Treatment","score":0.005200000014156103,"subfield":{"id":"https://openalex.org/subfields/2748","display_name":"Urology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/benign-prostatic-hyperplasia","display_name":"benign prostatic hyperplasia","score":0.8920000195503235},{"id":"https://openalex.org/keywords/dutasteride","display_name":"dutasteride","score":0.9850000143051147},{"id":"https://openalex.org/keywords/tamsulosin","display_name":"tamsulosin","score":0.9070000052452087},{"id":"https://openalex.org/keywords/combination-therapy","display_name":"combination therapy","score":0.8629999756813049},{"id":"https://openalex.org/keywords/cost-effectiveness","display_name":"cost-effectiveness","score":0.9020000100135803},{"id":"https://openalex.org/keywords/incremental-cost-effectiveness","display_name":"incremental cost-effectiveness","score":0.8889999985694885},{"id":"https://openalex.org/keywords/quality-adjusted-life-years","display_name":"quality-adjusted life years","score":0.8510000109672546},{"id":"https://openalex.org/keywords/semi-markov-model","display_name":"semi-Markov model","score":0.7689999938011169},{"id":"https://openalex.org/keywords/progression-risk","display_name":"progression risk","score":0.4729999899864197},{"id":"https://openalex.org/keywords/spanish-national-health-system","display_name":"Spanish National Health System","score":0.6069999933242798}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8859686851501465},{"id":"https://openalex.org/C15708023","wikidata":"https://www.wikidata.org/wiki/Q80083","display_name":"Humanities","level":1,"score":0.6381005048751831},{"id":"https://openalex.org/C138885662","wikidata":"https://www.wikidata.org/wiki/Q5891","display_name":"Philosophy","level":0,"score":0.0}],"mesh":[{"descriptor_ui":"D000068538","descriptor_name":"Dutasteride","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000077409","descriptor_name":"Tamsulosin","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001378","descriptor_name":"Azasteroids","qualifier_ui":"Q000191","qualifier_name":"economics","is_major_topic":true},{"descriptor_ui":"D001378","descriptor_name":"Azasteroids","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D003362","descriptor_name":"Cost-Benefit Analysis","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004359","descriptor_name":"Drug Therapy, Combination","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011470","descriptor_name":"Prostatic Hyperplasia","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D011470","descriptor_name":"Prostatic Hyperplasia","qualifier_ui":"Q000191","qualifier_name":"economics","is_major_topic":true},{"descriptor_ui":"D013030","descriptor_name":"Spain","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013449","descriptor_name":"Sulfonamides","qualifier_ui":"Q000191","qualifier_name":"economics","is_major_topic":true},{"descriptor_ui":"D013449","descriptor_name":"Sulfonamides","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D058668","descriptor_name":"Adrenergic alpha-1 Receptor Antagonists","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D058891","descriptor_name":"5-alpha Reductase Inhibitors","qualifier_ui":"Q000191","qualifier_name":"economics","is_major_topic":true},{"descriptor_ui":"D058891","descriptor_name":"5-alpha Reductase Inhibitors","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true}],"locations_count":3,"locations":[{"id":"doi:10.1016/j.acuro.2010.11.008","doi":"https://doi.org/10.1016/j.acuro.2010.11.008","is_oa":false,"landing_page_url":"https://doi.org/10.1016/j.acuro.2010.11.008","pdf_url":null,"source":{"id":"https://openalex.org/S38879697","display_name":"Actas Urol\u00f3gicas Espa\u00f1olas","issn_l":"0210-4806","issn":["0210-4806","1699-7980"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","doyens","jufo-1","norway-1","poland-40","russia-white-list-3"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Actas Urol\u00f3gicas Espa\u00f1olas","raw_type":"journal-article"},{"id":"doi:10.4321/s0210-48062011000200001","doi":"https://doi.org/10.4321/s0210-48062011000200001","is_oa":true,"landing_page_url":"https://doi.org/10.4321/s0210-48062011000200001","pdf_url":"https://scielo.isciii.es/pdf/aue/v35n2/original1.pdf","source":{"id":"https://openalex.org/S38879697","display_name":"Actas Urol\u00f3gicas Espa\u00f1olas","issn_l":"0210-4806","issn":["0210-4806","1699-7980"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","doyens","jufo-1","norway-1","poland-40","russia-white-list-3"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Actas Urol\u00f3gicas Espa\u00f1olas","raw_type":"journal-article"},{"id":"pmid:21269736","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/21269736","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Actas urologicas espanolas","raw_type":"Journal Article"}],"best_oa_location":{"id":"doi:10.4321/s0210-48062011000200001","doi":"https://doi.org/10.4321/s0210-48062011000200001","is_oa":true,"landing_page_url":"https://doi.org/10.4321/s0210-48062011000200001","pdf_url":"https://scielo.isciii.es/pdf/aue/v35n2/original1.pdf","source":{"id":"https://openalex.org/S38879697","display_name":"Actas Urol\u00f3gicas Espa\u00f1olas","issn_l":"0210-4806","issn":["0210-4806","1699-7980"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","doyens","jufo-1","norway-1","poland-40","russia-white-list-3"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Actas Urol\u00f3gicas Espa\u00f1olas","raw_type":"journal-article"},"sustainable_development_goals":[{"score":0.9763000011444092,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2004307680.pdf","grobid_xml":"https://content.openalex.org/works/W2004307680.grobid-xml"},"referenced_works_count":20,"referenced_works":["https://openalex.org/W1647631957","https://openalex.org/W1979512002","https://openalex.org/W2010913334","https://openalex.org/W2021853641","https://openalex.org/W2025029039","https://openalex.org/W2036880069","https://openalex.org/W2039370955","https://openalex.org/W2042729758","https://openalex.org/W2081597080","https://openalex.org/W2087842558","https://openalex.org/W2096881579","https://openalex.org/W2101761950","https://openalex.org/W2121759271","https://openalex.org/W2122664355","https://openalex.org/W2140741940","https://openalex.org/W2143943975","https://openalex.org/W2165635016","https://openalex.org/W2306998586","https://openalex.org/W2318393109","https://openalex.org/W2750095305"],"related_works":["https://openalex.org/W4323875048","https://openalex.org/W2034352604","https://openalex.org/W2613104418","https://openalex.org/W2541588855","https://openalex.org/W4241457895","https://openalex.org/W3190798218","https://openalex.org/W4251246775","https://openalex.org/W2072586667","https://openalex.org/W2163814631","https://openalex.org/W2080725168"],"abstract_inverted_index":{"ResumenObjetivos:":[0],"evaluar":[1],"el":[2,112,118,124,129],"coste-efectividad":[3],"incremental":[4],"(CEI)":[5],"de":[6,15,29,35,60,69,76,83,88,91,96,114,125,130,142],"la":[7,55,131],"combinaci\u00f3n":[8,132],"dutasterida":[9],"y":[10,37,50,122],"tamsulosina":[11,22],"(DUT":[12],"+":[13,127],"TAM)":[14],"inicio":[16],"frente":[17],"al":[18],"tratamiento":[19,105],"m\u00e1s":[20],"utilizado,":[21],"(TAM),":[23],"en":[24,74,109,111,123,140],"pacientes":[25],"con":[26,33,44],"hiperplasia":[27],"benigna":[28],"pr\u00f3stata":[30],"(HBP)":[31],"moderada-grave":[32],"riesgo":[34],"progresi\u00f3n.Material":[36],"m\u00e9todos:":[38],"se":[39,72,86,107,116,138],"dise\u00f1\u00f3":[40],"un":[41,45,89],"modelo":[42],"semi-Markov":[43],"horizonte":[46],"temporal":[47],"a":[48,51,63,133],"4":[49],"35":[52],"a\u00f1os":[53,75],"desde":[54],"perspectiva":[56],"del":[57,65,104,120],"Sistema":[58],"Nacional":[59],"Salud":[61],"espa\u00f1ol":[62],"partir":[64],"estudio":[66],"CombAT.La":[67],"efectividad":[68],"los":[70,136],"tratamientos":[71],"midi\u00f3":[73],"vida":[77],"ajustados":[78],"por":[79,99],"calidad":[80],"(AVAC).El":[81],"uso":[82],"recursos":[84],"sanitarios":[85],"obtuvo":[87],"panel":[90],"expertos.Los":[92],"costes":[93,137],"unitarios":[94],"proceden":[95],"tarifas":[97],"publicadas":[98],"las":[100],"Comunidades":[101],"Aut\u00f3nomas.El":[102],"coste":[103],"farmacol\u00f3gico":[106],"expresa":[108],"PVP-IVA;":[110],"caso":[113],"TAM":[115,128],"utiliz\u00f3":[117],"precio":[119],"gen\u00e9rico":[121],"DUT":[126],"dosis":[134],"fija.Todos":[135],"expresan":[139],"euros":[141],"2010.":[143]},"counts_by_year":[{"year":2024,"cited_by_count":1},{"year":2023,"cited_by_count":1},{"year":2018,"cited_by_count":1},{"year":2017,"cited_by_count":4},{"year":2016,"cited_by_count":3},{"year":2015,"cited_by_count":4},{"year":2014,"cited_by_count":1},{"year":2013,"cited_by_count":1},{"year":2012,"cited_by_count":2}],"updated_date":"2026-11-08T12:12:28.789561","created_date":"2016-06-24T00:00:00"}